Human Crohn’s Disease Leukopak

Description

Human Crohn’s Disease Leukopak consists of leukocytes collected through leukapheresis from donors clinically diagnosed with Crohn’s disease, a chronic inflammatory bowel disorder. Following isolation, the cells are cryopreserved. These immune cell preparations provide a valuable in vitro model for exploring the immunopathogenesis of Crohn’s disease, including dysregulated T cell responses, cytokine signaling, and epithelial barrier dysfunction. They are widely used for biomarker discovery, evaluation of anti-inflammatory agents, and personalized therapeutic development. Repeated freezing and thawing should be avoided. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.